4-hydroxy-N, N-dimethyltryptamine
GPTKB entity
Statements (26)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:chemical_compound
|
| gptkbp:bfsLayer |
6
|
| gptkbp:bfsParent |
gptkb:psilocin
|
| gptkbp:affects |
hallucinogenic
|
| gptkbp:class |
tryptamines
|
| gptkbp:composed_of |
alkylation
from tryptamine |
| gptkbp:discovered_by |
1970s
|
| gptkbp:dissolved |
soluble in water
|
| gptkbp:duration |
4-6 hours
|
| gptkbp:ecological_role |
psychoactive
|
| https://www.w3.org/2000/01/rdf-schema#label |
4-hydroxy-N, N-dimethyltryptamine
|
| gptkbp:ingredients |
C12 H16 N2 O
|
| gptkbp:legal_issue |
varies by country
|
| gptkbp:manager |
oral
|
| gptkbp:mass |
204.27 g/mol
|
| gptkbp:previous_name |
gptkb:4-hydroxy-N,_N-dimethyltryptamine
|
| gptkbp:products |
gptkb:DMT
|
| gptkbp:related_to |
gptkb:psilocybin
|
| gptkbp:research_interest |
psychedelic therapy
|
| gptkbp:safety_features |
not well studied
|
| gptkbp:side_effect |
nausea
|
| gptkbp:social_structure |
indole ring
|
| gptkbp:targets |
gptkb:drug
|
| gptkbp:type_of |
101-60-8
|
| gptkbp:used_in |
psychedelic research
|